The Compliance Conundrum The article “Pill Pushers or Partners in Progress” by Pai et al. (2024) revisits the ongoing debate on the ethical boundaries in the doctor–pharma relationship, particularly focusing on the sponsorship of Continuing Medical Education (CME). Triggered by the National Medical Commission's (NMC) August 2023 draft guidelines, which proposed banning pharmaceutical sponsorships, the article highlights the tension between ensuring ethical compliance and enabling knowledge exchange.
Though the guidelines were temporarily withdrawn following backlash from the Indian Medical Association (IMA), the controversy has reignited scrutiny over how deep-rooted pharma associations could bias medical decisions. What the Regulations Say Under the existing Medical Council of India (now NMC) Code of Ethics (2002, amended in 2009), doctors are explicitly prohibited from accepting any…
